Effect of a Posture Adapter for 12 to 24-month Children With Zyka Virus Syndrome

Sponsor
Universidade Federal de Pernambuco (Other)
Overall Status
Unknown status
CT.gov ID
NCT03227601
Collaborator
(none)
20
1
13.4
1.5

Study Details

Study Description

Brief Summary

Congenital Zika virus syndrome (SCZv) has been gaining attention in studies due to changes in the central nervous system and in the motor development of children. These changes resulted in an unexpected picture and without future predictability, with the appearance of several functional impairments and also on orthostatic posture. In this context, the protocol of orthostatism proposed here is a 10-week program of the use of a postural adjuster, the standing frame, made of its own with alternative material to the commercial models (cardboard). The use of low cost materials allows these devices to be made in the desired size without cost high, individually adapted, easy to be transported as it is light and can still be colored. It is an equipment that offers the opportunity to experience the orthostatic posture and mainly benefits children with little economic resources that enable the acquisition of traditional devices made of iron or wood and even imported equipment. The postural adjuster allows physical and sensorial opportunity, being an auxiliary resource in standing positioning, feasible for home use, besides being useful for performing functional activities. Thus, the objective will be to analyze the repercussions of the use of the standing frame on body alignment, muscle tone, gross motor function and gastrointestinal functions of children with SCZv. An uncontrolled intervention study will be conducted with children between 12 and 24 months of age, who will undergo an evaluation before use and after the use of the adjunct along with the proposed orthostatism protocol. The postural alignment will be evaluated through photogrammetry and the evaluation of muscle tone will be performed through the modified Tardieu scale. The Gross Motor Function Measure (GMFM) scale will be used to assess the gross motor function of the children involved in the study. Questionnaires will be applied for the collection of maternal socio-demographic data, the child's data, the type and time of therapy that the child already participates, and the gastrointestinal functions. Evaluations will occur in four moments: initial / before use, on the first day of placement in the adjuster, after the first month after use and after the second month of use. For statistical analysis, the Shapiro Wilk Test will be applied to evaluate the normality of the data, and the Friedman or ANOVA tests for repeated samples, to analyze intra-group time factor for the dependent variables of each individual.

Condition or Disease Intervention/Treatment Phase
  • Device: posture adapter
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of a Posture Adapter Use on Body Alignment in Standing Position on Children Between 12 and 24 Months Old With Zyka Virys Congenital Syndrome
Actual Study Start Date :
Jul 20, 2017
Anticipated Primary Completion Date :
Oct 19, 2017
Anticipated Study Completion Date :
Aug 31, 2018

Outcome Measures

Primary Outcome Measures

  1. Body Alignment [two-month period]

    Position or attitude of the body, the Arrangement of the parts of the body for a specific activity, or a Characteristic way of someone sustaining your body

Secondary Outcome Measures

  1. Motor function [two-month period]

    Ability to carry out human development stages

  2. Gastrointestinal function [two-month period]

    intestinal motility

  3. Muscular tonus [two-month period]

    basal level of muscle contraction

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Months to 24 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • children between 12 and 24 months old;

  • children with confirmed zika virus infection diagnosis;

  • children with STORCH + for zika virus (blood test)

Exclusion Criteria:
  • children with no medication for controlling zika virus infection symptoms;

  • children with musculoskeletal disorders or limitation to standing position

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universidade Federal de Pernambuco Recife Pernambuco Brazil 50.740-545

Sponsors and Collaborators

  • Universidade Federal de Pernambuco

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Labibe Mara Pinel Frederico, master's student, Universidade Federal de Pernambuco
ClinicalTrials.gov Identifier:
NCT03227601
Other Study ID Numbers:
  • 1808
First Posted:
Jul 24, 2017
Last Update Posted:
Jul 24, 2017
Last Verified:
Jul 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 24, 2017